XML 53 R37.htm IDEA: XBRL DOCUMENT v3.23.1
Equity (Tables)
12 Months Ended
Mar. 31, 2023
Equity [Abstract]  
Common Stock Reserved for Issuance
The Company has shares of common stock reserved for issuance as follows (in thousands):
March 31, 2023
Common stock warrants641 
2010 Plan
Options outstanding19,752 
2021 Plan
Awards outstanding
2,157 
Shares available for future grant31,112 
2021 ESPP6,243 
Options outstanding outside the Plans2,655 
Total62,560 
Stock Option Activity
Stock option activities within the Plans as well as outside of the Plans were as follows:
Number of Shares
(in thousands)
Weighted-Average
Exercise Price
Average Remaining Contractual Term
(in years)
Aggregate Intrinsic Value (in thousands)
Balance, March 31, 202226,983 $4.15 7.63$1,293,545 
Options exercised(3,717)2.65 
Options forfeited or expired(859)4.48 
Balance, March 31, 202322,407 4.39 6.56627,187 
Vested and exercisable as of March 31, 202311,897 2.58 5.62354,546 
Vested and expected to vest as of March 31, 202321,472 4.29 6.51603,118 
Stock Options Valuation Assumptions
The fair value of each option on the date of grant was determined using the Black-Scholes option-pricing model with the assumptions set forth in the following table:
Fiscal Year Ended March 31,
20222021
Fair value of common stock
$18.41 - $21.41
$2.06 - $10.51
Volatility
46.5% - 47.0%
38.1% - 58.3%
Risk-free interest rate
0.77% - 1.02%
0.26% - 1.02%
Expected term (in years)
5.00 - 6.09
5.00 - 8.00
Expected dividend—%—%
Restricted Stock Unit Activity
The following table summarizes RSU activity (in thousands, except per share information):
Number of SharesWeighted-
Average
Grant Date Fair Value
Unvested balance, March 31, 2022534 $68.23 
Granted1,863 34.27 
Vested(324)51.23 
Forfeited(122)44.93 
Unvested balance, March 31, 20231,951 40.08 
Stock-Based Compensation Expense
Total stock-based compensation expense recognized in the consolidated statement of operations was as follows (in thousands):
Fiscal Year Ended March 31,
202320222021
Cost of revenue$9,634 $4,979 $600 
Research and development12,583 7,065 1,975 
Sales and marketing16,939 8,108 1,998 
General and administrative8,678 11,290 2,679 
Total stock-based compensation expense$47,834 $31,442 $7,252 
Performance-Based Units Activity
The following table summarizes PSU activity (in thousands, except per share information):
Number of SharesWeighted-
Average
Grant Date Fair Value
Unvested balance, March 31, 202212 $80.00 
Granted213 34.63 
Vested(11)80.00 
Forfeited(8)38.47 
Unvested balance, March 31, 2023206 34.68